| 0 (0%) | 11-11 15:57 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.53 | 1-year : | 5.3 |
| Resists | First : | 3.88 | Second : | 4.53 |
| Pivot price | 3.68  |
|||
| Supports | First : | 3.37 | Second : | 3.05 |
| MAs | MA(5) : | 3.74  |
MA(20) : | 3.57 |
| MA(100) : | 3.48 |
MA(250) : | 3.17 |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 77.7 |
D(3) : | 80.1 |
| RSI | RSI(14): 58.4 | |||
| 52-week | High : | 3.93 | Low : | 2.29 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PYPD ] has closed below upper band by 41.8%. Bollinger Bands are 56.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 3.77 - 3.79 | 3.79 - 3.8 |
| Low: | 3.63 - 3.65 | 3.65 - 3.67 |
| Close: | 3.71 - 3.74 | 3.74 - 3.77 |
Tue, 11 Nov 2025
Analysts Are Bullish on These Healthcare Stocks: PolyPid (PYPD), Rezolute (RZLT) - The Globe and Mail
Mon, 10 Nov 2025
Applying Elliott Wave Theory to PYPD - Earnings Risk Summary & Short-Term Trading Alerts - newser.com
Sun, 09 Nov 2025
Is PYPD stock cheap at current valuation - Earnings Recap Report & Daily Volume Surge Signals - newser.com
Fri, 07 Nov 2025
PolyPid receives Nasdaq’s non-compliance letter - MSN
Thu, 06 Nov 2025
PolyPid Ltd.'s D-PLEX₁₀₀ Named "Therapeutics Solution of the Year" by BioTech Breakthrough - Quiver Quantitative
Thu, 06 Nov 2025
PolyPid (NASDAQ: PYPD) posts 58% SSI risk reduction; D-PLEX100 wins Therapeutics award - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 16 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 16.7 (%) |
| Held by Institutions | 41.2 (%) |
| Shares Short | 58 (K) |
| Shares Short P.Month | 52 (K) |
| EPS | -3.77 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.3 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -71.2 % |
| Return on Equity (ttm) | -312.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -1.96 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -26 (M) |
| Levered Free Cash Flow | -14 (M) |
| PE Ratio | -1 |
| PEG Ratio | 0 |
| Price to Book value | 2.85 |
| Price to Sales | 0 |
| Price to Cash Flow | -2.28 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|